The X-linked reproductive homeobox (RHOX) gene cluster encodes transcription factors preferentially expressed in reproductive tissues. This gene cluster has important roles in male fertility based on phenotypic defects of Rhox-mutant mice and the finding that aberrant RHOX promoter methylation is strongly associated with abnormal human sperm parameters. However, little is known about the molecular mechanism of RHOX function in humans. Using gene expression profiling, we identified genes regulated by members of the human RHOX gene cluster. Some genes were uniquely regulated by RHOXF1 or RHOXF2/2B, while others were regulated by both of these transcription factors. Several of these regulated genes encode we demonstrate how the X-linked RHOX gene cluster may function in normal human spermatogenesis and we provide evidence that it is impaired in human male fertility.
Introduction
It is estimated that 10-15% of couples are affected by infertility, and nearly half of the cases can be attributed predominantly to a male factor (1) . Some cases of male infertility are caused by known genetic defects, such as chromosomal abnormalities (e.g. Klinefelter syndrome) or Y chromosome microdeletions. However, a large proportion of infertile men (~30%) remain diagnosed with idiopathic infertility, i.e., no known underlying cause (1) (2) (3) . The X chromosome is of considerable interest to search for mutations that cause male infertility and subfertility, as this chromosome is enriched in testis-specific genes (4-7). Furthermore, mutations in X-linked genes have a complete penetrance due to their hemizygous state in men (8) . Despite this potential, only few X-linked genes have been studied with respect to human male fertility. Mutations in the X-linked androgen receptor (AR) gene have been shown to be associated with disorders in male sexual differentiation and development (9) . More recently, mutations in the X-linked gene, TEX11, have been identified as a cause of meiotic arrest and azoospermia (10, 11) .
In this report, we focus on a set of X chromosome-encoded transcription factors that previous studies have suggested are prime candidates to be involved in male infertility (12) (13) (14) (15) .
These reproductive homeobox (RHOX) transcription factors contain a homeodomain, a highly conserved 60 amino-acid DNA-binding domain that interacts with DNA through its third -helix (16) . Over 200 homeobox transcription factors are present in mammalian species, where they take over a diverse set of roles, including control of key steps during embryogenesis (17). The RHOX transcription factors are a distinct subfamily that differs significantly from other homeobox family members, including those in the well-known HOX and POU subfamilies (12, 18) . The human RHOX cluster is composed of three genes located in Xq24: RHOXF1 (hPEPP1, OTEX),
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RHOXF1 and RHOXF2/2B display highest expression levels in testis, and that the proteins are almost exclusively expressed in germ cells in a developmentally regulated manner (13) .
RHOXF1 is expressed in late stages of germ cell development (pachytene spermatocytes and round spermatids), while RHOXF2/F2B protein is expressed in early stages (spermatogonia and early spermatocytes; 13). The finding that RHOXF2/F2B and RHOXF1 are expressed predominantly in early and late stages of spermatogenesis, respectively, raises the possibility that they function in these stages, and that loss-of-function mutations in these genes are good candidates to perturb male gametogenesis in humans (4) . This is further supported by studies examining RHOX regulation. Both mouse and human RHOX family members have been demonstrated to be strongly regulated by DNA methylation (25) (26) (27) and there is an association between RHOX hypermethylation and abnormal sperm in idiopathic infertile patients (14) .
The possibility that the X-linked RHOX cluster has roles in human fertility is intriguing. In this report, we investigate the molecular mechanism of the human RHOX transcription factors and determine whether their function is negatively impacted in male infertility patients. Our studies identified mutations that debilitate human RHOX function and they provide a foundation for understanding the transcriptional networks downstream of RHOX transcription factors in male germ cells.
Results

Identification of genes regulated by RHOX transcription factors
To identify genes regulated by the RHOXF1 and RHOXF2/2B transcription factors, we performed microarray analysis in transiently transfected HEK293 cells (28) . These cells largely lack these two transcription factors, thus allowing us to perform gain-of-function analysis.
Transfection efficiency and RHOX protein localization were monitored and evaluated using fluorescence microscopy detection of GFP (Fig. 1A) . Interestingly, we found that the sub-cellular localization of RHOXF1 and RHOXF2/2B differed. While RHOXF1 expression was restricted mainly to the nucleus, RHOXF2/2B was found to be localized predominantly in the cytoplasm.
Ectopic expression of RHOXF1/RHOXF2 and RHOXF1/RHOXF2 protein was validated by qRT-PCR and Western blot analyses, respectively ( Fig. 1B and C) .
Microarray analysis of HEK293 cells 24h and 48h after transfection with the RHOXF1 and RHOXF2 expression vectors identified several genes that were significantly differentially expressed. In total, 17 (24h) and 37 (48h) transcripts were determined as differentially regulated in response to the RHOXF1 transfection vector compared to control vector transfection (fold Fig. 2A and B) . By combining results from both time points analysed, a deduced list of 8 RHOXF1 and 30 RHOXF2/2B unique protein coding DEGs was defined (Table 1) . Among these genes, RHOXF1 was found to be regulated by RHOXF2/2B, which would explain why these two RHOX transcription factors regulate some common genes (Supplementary Material, Table S3 ).
A subset of 8 candidate genes, composed of the 5 most strongly regulated genes (ANKRD1, DNAJB1, HSPA6, HSPH1, RHOXF1) and 3 regulated genes that have been previously associated with human fertilization (HSPA1A; (29, 30) and abnormal spermatogenesis (HSPA2, MSH5; (31, 32) , were selected for validation by qRT-PCR analysis.
This analysis confirmed that DNAJB1, HSPA1A, HSPA6, and HSPH1 were significantly upregulated by both RHOXF1 and RHOXF2/2B, whereas ANKRD1 was selectively upregulated in response to RHOXF2/2B overexpression (all p<0.01, Fig. 2C ). Also confirmed was that RHOXF2 regulates RHOXF1 (Fig. 2C) . This is of possible physiological relevance given that the former is mainly expressed in early stage germ cells (type-B spermatogonia and early spermatocytes), while the latter is predominantly expressed in late stage germ cells (pachytene spermatocytes and round spermatids; Fig. 2D; 13 ). RHOXF1 and RHOXF2/2B are not exclusively expressed by germ cells, since we noticed also very faint expression in somatic cells, e.g. Sertoli cells, Leydig cells and peritubular cells (Fig. 2D) .
To investigate the expression pattern of RHOX-regulated genes in the human testis, we performed qRT-PCR analysis on testis samples with either complete spermatogenesis or Sertoli cell only (SCO) syndrome (i.e. without germ cells). With the exception of ANKRD1, all RHOXregulated genes we tested were expressed in the testis, with HSPH1 (0.1917 ± 0.018) and DNAJB1 (0.1606 ± 0.012) showing the highest expression levels (Fig. 2E ). All these genes exhibited decreased expression levels in SCO testes compared to normal testes, suggesting that they are predominantly expressed in germ cells. For controls, we examined the expression of RHOXF1 (0.083 ± 0.025) and RHOXF2/2B (0.109 ± 0.034) and found they both exhibited dramatically decreased expression in SCO testes, consistent with the previous direct evidence that they are primarily expressed in germ cells in the human testis (13).
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Identification of RHOX sequence variations in infertile men
We next determined whether there are genetic alterations in RHOX genes in infertile men as a precursor to determining whether these mutations affect RHOX transcription factor function and thus are candidates to cause human spermatogenic defects. Towards this end, the coding region of RHOX was sequenced in 250 idiopathic infertile patients suffering from severe oligozoospermia (total sperm count ≤ 10x10 6 , concentration ≤ 5x10 6 /ml) to identify Single Nucleotide Polymorphisms (SNPs, minor allele frequency [MAF]>0.01) and rare genetic variants (also termed mutations, MAF<0.01). This analysis revealed a non-synonymous mutation c.515G>A (p.Arg172His) and a synonymous mutation c.522C>T (p.Asp174Asp) in RHOXF1 (Table 2) , both located downstream of the homeodomain (Fig. 3A) . We also identified four rare variants in RHOXF2/2B: a novel mutation in the 5'UTR (-73C>G), one in exon 4 (c.679G>A, p.Gly227Arg), and two known mutations in Exon 2 (c.202G>A, p.Gly68Arg, rs148604152 and c.411C>T, p.Asn137Asn, rs142963365; Table 2 , Fig. 3A ), all of which were confirmed by Sanger sequencing (Fig. 3B ). Clinical parameters of the patients carrying these variants are shown in the Supplementary Material, Table S4 . Analysis of 174 normozoospermic controls did not identify any of these variants with the exception of c.202G>A (Table 2) 
The effect of RHOX variants on protein function
To determine the impact of the sequence variations on RHOX function, expression vectors with the identified modifications were generated by site-directed mutagenesis. A frame-shift mutation (c.381dupG) in RHOXF2/2B leading to a premature stop codon and therefore to a truncated protein without the functional homeodomain (p.L128Afs*34) was used as a positive control.
Qualitative microscopic evaluation of the transfected cells revealed that all the mutant proteins exhibited normal localization ( Fig. 4A and B) , except for the truncated mutant, which lacks GFP 7 expression due to the premature stop codon. Fig. 4C and D shows the ability of these mutants to upregulate RHOX target genes that were identified in our microarray analysis (Fig. 2C) . The RHOXF2/F2B truncation mutant, c.381dupG, failed to upregulate the RHOX target genes, as it exhibited comparable expression values to empty control vector transfection. Futhermore, the c.202G>A and c.679G>A mutations in RHOXF2/2B caused a significant reduction in the expression levels of the ANKRD1, DNAJB1, HSPA1A, HSPA6, and RHOXF1 genes compared to ectopic expression of wild-type RHOXF2/2B (p<0.01; Fig. 4D ). This indicated that these two mutations compromised the ability of RHOXF2/F2B to regulate the transcription of its targets. In contrast, the RHOXF1 mutations had no effect on target gene regulation (Fig. 4C) .
To study the impact of two common RHOXF2/2B SNPs, c.277G>A and c.451C>T (Fig. 3) 
Modeling of RHOX protein structure
To determine the effect of the identified mutations on RHOX protein conformation we used three-dimensional homology modelling to predict the protein structure of RHOXF1 and RHOXF2/2B. Using Phyre 
Discussion
Spermatogenesis is a highly complex process that requires the concerted action of a large number of genes. Mutations in genes located on the X chromosome have a complete penetrance in the male population due to their hemizygous state and are therefore of primary interest to cause spermatogenic failure. One set of X-linked genes that are strong candidates to have a role in human infertility are those in the RHOX gene cluster. They encode transcription factors that are selectively expressed in the reproductive tract; in humans this gene cluster is mainly expressed in male and female germ cells (12) (13) (14) (15) . Mice with loss or depletion of Rhox genes exhibit male reproductive defects (12, 20) and human RHOX gene promoters are hypermethylated in sperm from men with abnormal semen parameters (14) . Here, we report the identification of specific genes regulated by the human RHOX transcription factors and we identify specific mutations in RHOX genes that disrupt their ability to regulate transcription.
One of the most striking findings of our investigation was that several RHOX-regulated genes encode chaperons belonging to the HSP70 family, including HSPA1A, HSPA2, HSPA6
and HSPH1 (Table 1 , Fig. 2A-C) . Such factors are critical for adaptive responses to stress and thus cell survival (33) . Several of these RHOX-regulated genes have been shown to have crucial roles in human male reproduction. For example, idiopathic infertile men who completely lack HSPA2 in their sperm exhibit impaired fertilizing ability (31, 34) and reduced expression of HSPA1A in ejaculated sperm has been implicated in the pathogenesis of male infertility (35).
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Very recently, aberrant methylation pattern of two closely related genes of HSPA1A, HSPA1B and HSPA1L, were associated with reduced fecundity (30) . DNAJB1 belongs to the HSP40 family and encodes a protein in human spermatozoa (29) that has also been localized to the sperm head and tail of rodent spermatozoa (36) . Given that HSP70 family members and other heat shock-induced proteins protect cells from heat stress, it is tempting to speculate that RHOX transcription factors regulate these genes to protect germ cells from heat stress. In support of this notion, spermatogenesis normally occurs at temperatures well below body temperature and thus deviations above this would require protection mechanisms. This is underscored by the fact that germ cells (particularly spermatocytes and spermatids) are exquisitely sensitive to elevated temperatures (37) . Our experimental design, using a control consisting of cells transfected with an empty vector, excludes that the heat shock proteins might be upregulated due to the transfection procedure.
Interestingly, we discovered that RHOXF1 is regulated by RHOXF2/2B (Table 1 , Fig. 2A -C) and thus it is likely that RHOXF1 is a RHOXF2/F2B target gene. As evidence that this regulatory relationship is physiologically significant, RHOXF2 protein is expressed in earlier stages of germ cell development than RHOXF1 ( Fig. 2D; 13) . We suggest that these two transcription factors function in "a cascade regulatory circuit" in which RHOXF2/F2B not only regulates genes critical for early stages of spermatogenesis (e.g. in spermatogonia and leptotene and pachytene spermatocytes) but is also responsible for driving the expression of RHOXF1, which serves as the next transcription factor in a temporal development pathway by regulating genes critical for later stages of spermatogenesis (e.g. in spermatids). In support of the notion that RHOXF2/F2B regulates RHOXF1, we identified several genes co-regulated by these two transcription factors (Supplementary Material, Table S3 ). This regulative scenario also enables RHOXF1 and RHOXF2/2B to maintain some common functions despite major sequence differences and distinct expression pattern. We note that even though RHOXF1 was not detectable after the round spermatid stage (13) , its influence may extend beyond this stage, as many mRNAs transcribed in the round spermatid stage are translated and function at later stages (38) .
Another major finding of our study was the discovery that human idiopathic infertile patients have RHOX mutations. We identified two mutations in RHOXF1 and four in RHOXF2/2B in patients with severe oligozoospermia, of which only one (c.202G>A) was also detected in the control group with normal sperm concentrations ( Table 2) . We note that a similar mutation frequency was observed in the ExAC database (exomes from 60,706 individuals derived from different studies [http://exac.broadinstitute.org/about]) which can be explained by the fact the 10 ExAC dataset includes exomes from infertile men as well. Interestingly, we observed more genetic variants for RHOXF2/2B than RHOXF1, consistent with a previous study showing that there was more rapid evolution of RHOXF2/2B than RHOXF1 in primates (24) . Most of the RHOXF2/2B variants we identified were located in exon 2 (Fig. 3A) . This encodes the homeodomain N-terminal region, which is of interest given that this region is involved in protein-protein interactions that modulate homebox transcription factor target gene specificity and transcription rate (19, 23) . We suggest that mutations in this region might disrupt functional interactions of RHOX proteins with other proteins (such as heterodimeric transcription factor partners) and might even allow RHOX proteins to gain new functional properties.
Our functional analysis showed that both the c.202G>A and c.679G>A mutations significantly impaired the ability of RHOXF2/2B to upregulate the expression of several of its downstream genes (Fig. 4D ). This critical data indicated that the c.202G>A and c.679G>A
mutations impair the ability of RHOXF2/2B to function. Therefore, these mutations have the potential to impair the in vivo function of RHOXF2/F2B and thus perturb human spermatogenesis. A caveat is that we used a cell line for these studies and thus our results do not necessarily reflect the in vivo situation. Nevertheless, we could show that the identified target genes were also expressed within the testis (Fig. 2E) and data available at the human protein atlas repository (39) display their germ cell specific expression at the protein level. Thus the identified RHOX network is presumably not restricted to the HEK293 cell system. Moreover, our protein modeling indicated that both the c.202G>A and c.679G>A mutations are predicted to alter the tertiary structure of RHOXF2/2B protein (Fig. 5) , providing further weight to the argument that these mutations cause deleterious effects. Both mutations lead to a Glycine being replaced by an Arginine, whose larger amino acid side chain could lead to altered protein folding as a result of steric interactions with the surrounding molecules. Furthermore, the mutated amino acid side chains change from a neutral charge to a positive charge. These alterations, in turn, can lead to modified binding properties of already existing target genes or enable novel interactions with different cofactors to regulate a new set of targets. The c.202G>A mutation impacts the region upstream of the homeodomain, a region that is known to be a protein-protein interaction domain in other homeobox proteins (19, 23) . Our finding that the c.202G>A mutation is present with a similar frequency in the control group indicates that this mutation alone is not sufficient to cause severe oligozoospermia. Instead, this mutation might predispose individuals to infertility and/or cause a more modest (subfertile) phenotype. In contrast to c.202G>A, we observed that c.679G>A only occurred in our patient group which indicates that this mutation might cause severe oligozoospermia. As a limitation of this study, we could not distinguish whether mutations occurred in RHOXF2 or RHOXF2B, as the two gene paralogs are almost identical (13, 14) . In the future, it will be interesting to identify men who are double hemizygous (i.e. have loss-of-function mutations in both RHOXF2 and RHOXF2B), as this would allow one to exclude compensatory mechanisms that might mask a more severe effect of complete loss of RHOXF2 function.
A relatively unusual feature of RHOX proteins is their cytoplasmatic accumulation. In contrast, most homeobox proteins and other transcription factors are localized in the nucleus, where they bind DNA and modulate transcription. Only in exceptional cases are transcription factors retained in the cytoplasm or exported from the nucleus to the cytoplasm, where they are either sequestered from regulating transcription or confer different activities in the cytoplasm, such as modulating translation (40) (41) (42) . RHOXF1 and RHOXF2 differ in their subcellular localization. In the fetal testes, RHOXF1 is predominantly expressed in the nucleus, while RHOXF2/2B is mostly restricted to the cytoplasm (13) . We observed the same differential localization pattern of these two proteins in transfected HEK293 cells (Fig. 1A) . In contrast, RHOXF1 and RHOXF2/2B are expressed in both the nucleus and the cytoplasm of adult testes ( Fig. 2D; 13) . Because RHOX proteins are relatively small (RHOXF1: 20.5 kDa, RHOXF2/2B: 31.6 kDa; 13), they do not require active mechanisms to pass through the nuclear pore into the cytoplasm and thus their presence in the cytoplasm may simply reflect excess proteins that are not actively regulating translation.
In this work, we coupled genetic and transcriptional analyses with functional validation and in silico modeling to uncover molecular mechanisms by which RHOX transcription factors function in the context of male fertility. We suggest that the RHOX transcription factors and some of their downstream genes represent new potential targets to be use for the diagnostics and treatment of male infertility.
Material and Methods
Study population
All subjects in this study were attending the Department of Clinical Andrology at the Centre of 
DNA Isolation, Library Preparation and Sequencing
Genomic DNA was isolated from 1ml EDTA-preserved blood using the FlexiGene DNA extraction kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. The quantity and quality of DNA was evaluated using NanoDrop1000 spectrophotometer (Thermo 
SNP Genotyping
Genomic DNA was isolated using DNA Extract All Reagents Kit (Applied Biosystems, Carlsbad, CA, USA) according to the product protocol and samples were stored at 4°C over night before use. TaqMan GTXpress Master Mix and a customized TaqMan genotyping assay mix (Applied Biosystems, Assay no. AHOI4J0, AHLJSWI) were used for genotyping RHOXF2/2B c.277G>A 
Gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG)
pathway analysis were performed using DAVID (https://david.ncifcrf.gov; 55). The p-value < 0.05 and count > 2 were applied as cut-off criteria to identify over-represented biological categories.
For RHOXF1 no significant GO could be determined due to low numbers of DEGs Ingenuity pathway analysis (IPA, Qiagen, www.qiagen.com/ingenuity) software was used to evaluate molecule connectivity. Genes of interest were assigned to specific biologically significant networks based on known associations in the databases and ranked as to their biological relevance. Microarray data obtained in this study were submitted to the GEO database (accession number: GSE84463).
qRT-PCR
RNA was isolated as described above. A total of 500 ng of mRNA were transcribed into cDNA using iScript cDNA synthesis kit according to the manufacturer's protocol (Bio-Rad, Hercules, CA, USA). Quantitative real-time PCR analyses were conducted using SYBR®-Green reagents on a StepOnePlus PCR system (Applied Biosystems). All samples were measured in duplicates and data analysis was performed using the StepOnePlus software 2.2.1. (Applied Biosystems).
Primer sequences are listed in Supplementary Material, Table S6 . Results were normalized using GAPDH as internal control and shown as 2 -ΔCt values (49) .
Western blot analysis
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Western blotting analysis was performed as previously described (13) . Briefly, 50µg of total cell lysates was electrophoresed in 12% SDS-PAGE transferred to Immobilon-P PVDF membrane (Millipore) and probed with custom generated antibodies against RHOXF1 or RHOXF2/2B
(ProteinTech Group Inc., Chicago, IL; 13) and β -ACTIN (Sigma Chemical Co., St. Louis, MO).
The membranes were washed 3x10 min with 0.1% Tween-20 in phosphate-buffered saline and then incubated for 1h at room temperature with the secondary antibody (ECL anti-rabbit or antimouse; GE Healthcare UK). Afterwards, membranes were developed using the Super Signal
West Pico Chemiluminescent substrate (Thermo Scientific, Rockford, IL).
Immunohistochemical analysis
Immunohistochemical analysis was performed on paraffin-embedded testis tissue that were Fig. S4C ) and the tertiary structure modeled as for full length RHOX. The best predicted models were selected and visualized using UCSF Chimera v.1.10.2. Mutated amino acids for the identified non-synonymous mutations and SNPs were introduced with the chimera rotamere tool.
Highest ranked rotamers were chosen for each variation and used to identify interatomic clashes and contacts of the substituted amino acid with the surrounding atoms.
Statistical analysis
Significant differences between RHOX expression and RHOX target gene expression levels were obtained using Mann-Whitney test with a 95% confidence level. Adjustment of p-values for multiple testing was performed using the Bonferroni post hoc test. All statistical calculations were performed using GraphPad Prism v.5.00 (GraphPad Software, La Jolla, CA, USA) and results were presented as mean ± SEM unless stated otherwise. Each insert shows the identified non-synonymous mutations (grey) and SNPs (black) as sticks. 
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